NEFIN Group Enters Singapore with A Goal to Invest SGD$100million In Upcoming 5 Years

Media Outreach
-
0

Partnering with Tuas Power Supply is the First Step in Materializing the Long-term Commitment into Singapore. There are more strategic partnerships in the pipeline this year.

SINGAPORE – Media OutReach – 11 August 2022 – NEFIN Group (“NEFIN”), Asia’s leading green independent power producer (IPP), officially launched its brand-new APAC Headquarters in the heart of Singapore’s downtown precinct at MacDonald House in Dhoby Ghaut. Highly driven by the entrepreneurial spirit of Singapore, 8 August 2022 marked an important milestone for NEFIN since its inauguration in 2014.

www.nefinco.com for more information and follow us at .

About Tuas Power

Tuas Power is a key provider of energy solutions and multi-utilities in Singapore, and is a member of China Huaneng Group, one of the largest and most forward-looking power producers in China and the world. We welcome innovation and strategic partnerships while embracing change sustainably.

Tuas Power has a licensed capacity of 2,670 MW and is a leading power generation company in Singapore. It has five combined cycle plants and a steam plant in its power station in the Tuas industrial region and develops efficient and environmentally responsible energy solutions through its retail arm. Tuas Power also supplies utilities such as steam, high-grade industrial water, demineralised water and waste water treatment services in Tembusu, Jurong Island. In April 2022, it added desalination capabilities to its portfolio of businesses with the launch of the jointly-developed Jurong Island Desalination Plant. Visit www.tuaspower.com.sg

About Tuas Power Supply
Tuas Power Supply (TPS) is the electricity retail arm of Tuas Power Generation. A leading player in the liberalized Singapore electricity market, TPS serves customers from a wide spectrum of industries. TPS develops and provides different cost-effective energy solutions to customers, to fulfil their energy requirements.

About ACEN

ACEN is the listed energy platform of the Ayala Group. The company has ~4,000 MW of attributable capacity in the Philippines, Vietnam, Indonesia, India, and Australia, with a renewable share of 87%, which is among the highest in the region.

ACEN’s aspiration is to be the largest listed renewables platform in Southeast Asia, with a goal of reaching 20 GW in renewables capacity by 2030. In 2021, ACEN announced its commitment to achieve Net Zero greenhouse gas emissions by 2050. This will involve the early retirement of its remaining coal plant by 2040 and transition the company’s generation portfolio to 100% renewable energy by 2025.

Stella Damasus Joins NW Tech Capital As Lead Talent Acquisition Consultant

Brand Spur
-
0
Stella Damasus Joins NW Tech Capital As Lead Talent Acquisition Consultant

Delivering on our promise to be a global leader in the Beauty and Wellness Industry, NW Tech Capital (www.NWTTCapital.com ) and TROPICSLAB is pleased to announce that award winning Nollywood celebrity Stella Damasus, has joined us, as lead Consultant for talent acquisition of the Company’s Beauty and Wellness division in its African expedition.

Stella Damasus is a highly celebrated Nigerian celebrity (actor/singer) with a refined skill and several years of experience and expertise, traveling and empowering celebrities across Africa.

She is tasked with the responsibility to expand the company’s tentacles by acquiring the best talents to fulfill our vision of establishing a flurry of high-end celebrity cosmetic brands across Africa.

NW Tech Capital is a publicly traded diversified holding company (OTC: NWTT) that was founded in1996, actively involved in the acquisition and investment of small, mid-size and development-stage private businesses in varied industries.

Based on Tropicslab’s clinically tested formula, over the next Five (5) years, NWTT projects to invest at least One Hundred Million Dollars ($100,000,000) in Africa, in Skincare research and development, manufacturing, distribution, marketing, to generate substantial revenue for our shareholders and to help combat skin cancer for people of color.

“Stella brings with her a wealth of experience and refined skill in talent acquisition that is almost unparalleled in today’s market,” said NWTT CEO Cedric Yengo. “With her extensive connections in the industry and her acumen for strategic alliances, we believe that Stella will help us to position ourselves as the premier Beauty and Wellness Company, in the nearest future”.

According to Edith Delight CEO of Tropicslab, “The Task Force led by Stella Damasus will begin accepting applications from celebrities immediately, for the creation of high end celebrity cosmetic brands”.

eWTP Arabia Capital ranks among Top 50 Best Performers and Rising Stars in China

Media Outreach
-
0
  • Riyadh-headquartered fund listed among ‘Top 50 Investors of Direct Investment Funds with Best Performance in 2022’ and ‘Top 30 Best Rising Star Funds in 2022’
  • Recognition follows success in building bridge between China and the MENA region for technology- and expertise-sharing

RIYADH, SAUDI ARABIA/DUBAI, UAE – Media OutReach – 11 August 2022 – eWTP Arabia Capital (eWTP), one of the largest Middle East and North Africa (MENA)-focused growth stage venture fund creating robust digital ecosystems in emerging markets, has been recognized for its role and achievements in improving the digital and technological collaboration between experts and organisations in China and the Middle East North Africa (MENA) region. The China Fund of Funds Research Centre（China-fof.com）, in their 2022 rankings, listed Jerry Lee, Founding and Managing Partner, eWPT Arabia Capital within ‘Top 50 Investors of Direct Investment Funds with Best Performance in 2022‘ and the firm within ‘Top 30 Best Rising Star Funds in 2022‘.

www.ewtparabia.com

Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing the total Series D Financing to $95 Million

Media Outreach
-
0
HIGHLIGHTS:

  • In challenging market conditions, Insilico Medicine closed Series D2 round, bringing the total Series D financing to $95 million from global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
  • Series D2 round is led by Prosperity7, the diversified growth fund of Aramco Ventures, which is an investment subsidiary of Aramco, the world’s leading integrated energy and chemicals company
  • The investment from Prosperity7 will further support Insilico Medicine’s Environmental, Social and Governance（ESG）objectives that span beyond biomedicine to actively address global climate change and support sustainable development of ecosystems

HONG KONG SAR – Media OutReach – 11 August 2022 – Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has received Series D2 financing round, led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures, bringing the total Series D financing to $95 million. This round is also participated by other global investors with expertise in investing in the biopharmaceutical and life sciences sectors.

The financing brought in Prosperity7 as a new investor, alongside current investors in the Series D round, including a large, diversified asset management firm on the US West Coast, B Capital Group, Warburg Pincus, BHR Partners, Qiming Venture Partners, Deerfield, Pavilion Capital, BOLD Capital Partners and WS Investment Company. Insilico’s founder and CEO, Alex Zhavoronkov, PhD, also invested in the Series D round.

Aysar Tayeb, Executive Managing Director of Prosperity7 Ventures, said: “The deepening application of AI and machine learning for drug discovery has demonstrated a transformative positive impact on the pharmaceutical industry and we are delighted to embark on this partnership with Insilico Medicine, a frontrunner in this innovation. Backed by the breadth of Aramco’s ecosystem across geographies and sectors, we look to support the company to scale up and expand its footprint globally, to drive biotechnology excellence, and to bring positive impact for greater wellbeing.”

The new Series D capital will support the continued advancement of Insilico’s pipeline, including its lead program which is currently in a Phase 1 study in New Zealand and in China, as well as several pipeline programs in IND-enabling studies. The proceeds will also fund other key strategic initiatives, including further development of its end-to-end Pharma.AI platform, the launch of a fully automated, AI-driven robotic drug discovery laboratory and biological data factory, and the establishment of regional centers.

Insilico Medicine has multiple Environmental, Social and Governance（ESG）objectives that span beyond biomedicine. The investment from Prosperity7 further diversifies the Company’s investor base globally and brings a potential strategic partner with deep expertise in high-performance and environmentally friendly energy R&D. Relying on Prosperity7’s global network and generous resources, Insilico will expand its AI capabilities from drug R&D to multiple areas, including sustainable chemistry, green energy, and agriculture to actively address global climate change and support sustainable development of ecosystems. Prior to the launch of ESG strategy, Insilico has already harnessed the power of its platform to accelerate innovation in sustainable agriculture in a multi-year collaboration with Syngenta which validated that Insilico’s platform capabilities in AI-enabled multiparameter optimization could create substantial value.

“In 2022 Aramco became the world’s most valuable company, and we are deeply honored to receive the investment from their venture capital arm, Prosperity7 which focuses on investment in ‘disruptive technology’,” said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. “Our experience in expanding our reach into sustainable agriculture where we collaborate with Syngenta and others demonstrated that the diversity of data and methods and unprecedented scale up allows us to improve our performance in drug discovery. I am certain that the upcoming collaborations with Prosperity7 in the field of sustainable and environmentally friendly chemistry and clean energy solutions will further expand our artificial intelligence capabilities. In addition, after spending time in Saudi Arabia, it is clear that the country is making a giant leap in technology, and we would like to be part of it and help the country realize its vision faster using the latest advances in artificial intelligence.”

Through a unique dual-CEO structure, Insilico Medicine is advancing its AI capabilities and drug research and development simultaneously. Recently, the Company promoted Dr. Feng Ren, Insilico’s Chief Science Officer (CSO) to the position of co-CEO to drive the company’s drug R&D platform. In addition to overseeing drug discovery and development, Dr. Ren will also guide the Company’s growing clinical development and will play a leading role in driving business development. During his tenure, the Company has rapidly transformed its pipeline into a robust portfolio of novel, innovative drug candidates, targeting areas with highly unmet needs. Seven programs in its internal pipeline have progressed to IND-enabling studies, including a novel 3CL protease inhibitor for COVID-19 treatment, and two synthetic lethality programs targeting MAT2A and USP1 for oncology indications. It also successfully completed a Phase 0 microdose study in Australia and entered Phase I clinical trials with its first internally developed program targeting fibrosis in both New Zealand and China.

“We have the structure in place as an equal parts AI and drug development company,” said Feng Ren, PhD, co-CEO and CSO of Insilico Medicine. “We also have a number of exciting initiatives in motion – including an expanding global presence, a robotics lab in development, and significant progress on our internal pipeline programs. With this latest funding round, we will be able to scale up our capabilities, advance our internal programs, develop our AI, and align with partners in the Saudi region to develop new regional technology hubs.”

Insilico has co-development and software licensing deals with a number of major pharmaceutical companies. Since the launch of its PandaOmics™ and Chemistry42™ platforms in late 2020, nine out of the top 20 pharmaceutical companies, as measured by 2020 revenue, have used Insilico’s AI platforms. In 2022, Insilico signed multi-asset partnerships with Fosun Pharma and EQRX in January and March, respectively. Notably, Insilico achieved its first major milestone and nominated a preclinical candidate for the QPCTL program for cancer immunotherapy less than 40 days into the strategic collaboration with Fosun Pharma. Business development continues to remain a vital part of the company’s strategy to demonstrate and unlock the value of its Pharma.AI platform.

Hashtag: #InsilicoMedicine

The issuer is solely responsible for the content of this announcement.

About Insilico Medicine

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and to design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases and aging-related diseases.

For more information, visit

McKay Brothers Launches the Fastest Transpacific Market Data and Private Bandwidth Services

Media Outreach
-
0

New ultra-low latency services connect key Illinois and Asia exchanges

Geneva, Paris, Oakland, CA – News Direct – 11 August 2022 – McKay Brothers’ MBI team has launched the lowest known latency market data services between Illinois’ largest futures exchanges and key Asia trading centers in Tokyo, Singapore and Hong Kong. MBI has also launched Transpacific private bandwidth services that are faster than any known alternative.

“We are thrilled to redistribute key instruments from CME, ICE, and JPX at the lowest known latency between Asian and US exchanges,” said Francois Tyc, MBI’s Managing Director. “In addition to our latency being differentiated, both our private bandwidth and market data services are provided on a level playing field for all subscribers.”

MBI’s industry-leading Quincy Extreme Data (QED) platform is a normalized market data feed of select instruments from leading financial exchanges. With this latest service, QED’s US-sourced data is redistributed in Tokyo-CC2, Singapore, and Hong Kong. Tokyo-sourced data is redistributed in Aurora, IL, Singapore, and Hong Kong. All are redistributed at the lowest known latency.

The QED Transpacific service offers a package of select futures market data, including equity indexes, interest rates, FX, agricultural/softs, energy, metals and crypto futures. Further details and coverage of the QED data symbol set are available or

African Development Bank Appoints Dr. Alex Mubiru As Director General, Cabinet Office

Brand Spur
-
0
African Development Bank Appoints Dr. Alex Mubiru As Director General, Cabinet Office

The African Development Bank  has appointed Dr. Alex Mubiru as Director General in the Cabinet Office of the Bank Group’s President, with effect from 16 August 2022.

Dr. Mubiru, a Ugandan national, brings close to 25 years of experience to the position, with a proven track record in the various positions he has held at the African Development Bank, and elsewhere.

Mubiru has been Acting Director General in the Cabinet Office of the President since December 2021 and Director of Strategy and Delivery, in the same office.

Mubiru joined the Bank as Principal Research Economist in 2009 and has since served in various other roles. Between 2010 and 2012, he was Principal Country Economist in the Tanzania Country Office. In 2012, he was appointed Lead Strategy Advisor in the Strategy and Operations Policy Department and was part of the core group that coordinated the development of the Bank’s 2013-2022 Ten-Year Strategy. During the same period, he also served as Task Manager for the preparation of the Bank’s 2013-2017 Private Sector Strategy. In 2014, he was appointed Manager in the Resource Mobilization Department, where he was part of the core team that led, organized and coordinated the 14th replenishment of the African Development Fund. In 2018, he was appointed as Country Manager in the Tanzania Country Office, where he managed a portfolio of over $2.3 billion.

Prior to joining the African Development Bank, Mubiru worked as Assistant Professor of Social Science at the Singapore Management University (2008-2009), Assistant Professor of Public Policy at the Lee Kuan Yew School of the National University of Singapore (2001-2008), Project Economist at the World Bank in Thailand (1999-2001) and Research Associate at the Thailand Development Research Institute (1994-1995).

“I am deeply touched and inspired by President Adesina for the confidence he has, once again, placed in me with this appointment,” Mubiru said. “I greatly look forward to working with the rest of the Cabinet as well as Senior Management to support the President as he steers the Bank towards the successful implementation of the stated goals of his second mandate. The Bank has given so much to me ever since I joined, and I shall endeavor to work to the best of my abilities, and use my potential to the utmost, to give back as much to it, while serving in this role.”

Mubiru holds a PhD and a master’s degree in Public Affairs, both from Princeton University, and a Bachelor of Arts (cum laude) in Philosophy, Political Science and Economics from Macalester College, USA.

Commenting on the appointment, the President of the African Development Bank Group, Dr. Akinwumi A. Adesina, said: “Alex’s well-rounded experience as part of the senior leadership team in my cabinet office as well as elsewhere in the institution will allow him to support me effectively at a crucial time in the institution’s history. He brings deep institutional knowledge, a solid track record and a quiet maturity to the role. I am confident that he will have an immediate impact in streamlining strategic initiatives, overseeing program management, and communicating objectives across the institution.”

The Bulls Suppress The Bears In The Local Bourse, NGX ASI Rebounds By 147bps

Brand Spur
-
0
The Bulls Suppress The Bears In The Local Bourse, NGX ASI Rebounds By 147bps

Yesterday’s trading session saw the Nigerian All Share Index closed positive, appreciating by 1.47% to close at 50,075.47 points.

The performance was due to buying pressures in large-cap stocks such as DANGCEM (+9.96%) and GUINNESS (+1.20%). Consequently, the YTD return increased to 17.23% as market capitalisation improved by ₦390.91 billion to close at ₦27.01 trillion.

The sectoral performance totally strengthened as all the five indices under coverage improved. The Industrial index, the biggest gainer, rose by 4.83% on DANGCEM (+9.96%). The Insurance, Banking, Consumer goods and Oil & Gas indices followed suit, improving by 1.91%, 0.42%, 0.33% and 0.06% on NEM (+9.89%), ZENITHBANK (+0.94%), GUINNESS (+1.20%) and ETERNA (+2.80%) respectively.

Investors’ sentiment strengthened as the market breadth increased to 2.00x from 0.75x. This was illustrated by the advance of 20 stocks, led by DANGCEM (+9.96%) and NEM (+9.89%) and the decline of 10 stocks, led by WAPCO (-8.84%) and NAHCO (-8.62%). Activity level strengthened as the total volume and value improved by 98.58% and 30.14% respectively, as investors exchanged about 279.22mn units of shares worth over ₦2.08bn.

We expect positive sentiment to persist in the next trading session as the equities market still presents decent opportunities for investors chasing positive real returns on investments.

 Fixed Income

There was mixed sentiment across the bond yield curve as two of the four bond yields under coverage closed flat, the yield on the FGN-APR-2023 increased by 168bps while the FGN-MAR-2024 bond yield compressed by 1bp. The yields on the FGN-JAN-2026 and FGN-JUL-2030 bonds closed flat at 12.35% and 12.49% respectively.

The Treasury bill yields for the 91, 182 and 364-day papers closed flat at 6.08%, 7.77% and 6.81% respectively.

We expect market activity to be influenced by the liquidity levels in the financial system.

MARKET SNAPSHOT

  • The Bulls Suppress the Bears in the Local Bourse, NGX ASI Rebounds by 147bps
  • Mixed Sentiment across the Bond Yield Curve
  • Negative Performance in Global Stocks
  • Brent Crude Reports @ $95.78/barrel
  • Positive Performance in African Stocks

Japan’s Wealthiest Man Commits Eighty Million Dollars In Beauty Deal With Tropics-Lab

Brand Spur
-
0
Japan’s Wealthiest Man Commits Eighty Million Dollars In Beauty Deal With Tropics-Lab

Tropicslab  is a privately owned company by Dr. Edith F. Gibson, an innovative scientist who spent the last seven years researching and perfecting the adequate formula to produce an impeccable skin care formula for people with skin of color.

Tropicslab is actively making huge strides in spreading its skincare tentacles across Africa and North America to revolutionize the skincare industry.

Through international strides and relationship building, Cedric Yengo the CEO of NW Tech Capital, Inc arranged for a confirmation pitch between Tadashi Yanai in order to provide exclusive skincare to the retail giant.

Known for his keen business eye and witty investments, Tadashi Yanai has grown to become a worldwide phenomenon and a force to reckon with in the business world. In a recent commitment deal intended to combat skin cancer and providing clinically approved skincare products, he has committed to Tropicslab, the $80,000,000 skincare deal. Tadashi Yanai has confidence and he believes that with adequate research, necessary improvements in healthcare will be achieved.

Tropicslab is set to release a flurry of celebrity skin care brands based on: different country climatic conditions, local country ingredients, FDA regulations per country, shipping and custom duties, purchasing power and supply chain differences per country and Joint research with country-specific local research skin care teams.

The multimillion dollar deal is expected to become effective by the end of August 2022 and shall cover not only clinical research, but also manufacturing and distribution of products for celebrity skincare brands.

CEO of Tropicslab, Dr. Edith Gibson said, “we are excited that our vision has attracted the attention it deserves. We are on a journey to revamp the beauty and wellness industry and we shall do so without hesitation. We have a clear cut objective and shall see to its accomplishment. This is simply a start for us and better things are coming on ahead.”

FIFA+ To Live Stream FIFA U-20 Women’s World Cup Costa Rica 2022 ™ In 114 Territories

Brand Spur
-
0
FIFA+ To Live Stream FIFA U-20 Women’s World Cup Costa Rica 2022 ™ In 114 Territories

FIFA+ to broadcast all matches of the FIFA  U-20 Women’s World Cup™ for free in over 100 territories, giving fans across the world access to new depths of the women’s game; The tournament will be live for fans in trophy hopeful nations Brazil, Germany, Ghana and Nigeria, and in major women’s football hubs like England and Sweden; The 16-team tournament – held in Costa Rica – kicks off with Germany against Colombia on 10th August, before the final is played in San Jose on 28th August.

The FIFA U-20 Women’s World Cup 2022™, which will be hosted in Costa Rica between 10th and 28th August, is set to be broadcast live for free on FIFA+ in over 100 territories, bringing audiences from across the globe all new access to tomorrow’s stars of the women’s game.

Matches will be live on FIFA+ in 114 countries, including tournament hopefuls Germany, Brazil, Ghana and Nigeria. FIFA+ will also be the home for fans in women’s football powerhouses England and Sweden.

Aside from the live match coverage, FIFA+ will also be the home of premium editorial content for the tournament, tracking news, interviews and analysis throughout.

The FIFA U-20 Women’s World Cup™ has long been a hotbed of emerging talent, with previous stars including USA’s Sydney Leroux, Germany’s Alexandra Popp and Dzsenifer Marozsán, and Nigeria’s Asisat Oshoala – who stars in Episode 3 of the FIFA+ Original Series, Icons (https://fifa.fans/3PcDfp1).

Find out more about the FIFA U-20 Women’s World Cup Costa Rica 2022™ (https://fifa.fans/3bQRqCB) now.

Charlotte Burr, FIFA Director of Strategy, Development, and FIFA+, said:

“After a summer that has seen women’s football capture the hearts and minds of fans around the world, with continental champions crowned in every major region, we’re delighted to be bringing the stars of tomorrow to the world on FIFA+.

“For years, the FIFA U-20 Women’s World Cup™ has been a fascinating window into the next generation of superstars in the women’s game, and 2022 promises to be no different. Costa Rica will provide a stunning backdrop to elite football and drama aplenty – we’re excited to be bringing fans around the world closer to the tournament and the future stars of the women’s game.”

SEACOM And British Telecommunications (BT) Team Up To Deliver Enterprise Communications Services In Africa

Brand Spur
-
0
SEACOM And British Telecommunications (BT) Team Up To Deliver Enterprise Communications Services In Africa

SEACOM  and BT today announced a strategic alliance which will help SEACOM further secure its own infrastructure and deliver new networking, security and communications solutions to enterprise customers in Africa.

As a leading Internet connectivity supplier that owns Africa’s most extensive ICT infrastructure, SEACOM will be leveraging BT’s services, vendor relationships and global expertise to expand its portfolio of services aimed at African businesses. Since the launch of its Business division, SEACOM has substantially grown its customer and partnership base to strengthen its offerings and serve customers beyond existing markets.

SEACOM’s customers will benefit from access to BT’s Cloud Security Incident Event Management (SIEM) platform. In today’s business environment data, business applications and users live beyond an organisation’s traditional network. SIEM tools provide real-time visibility and monitoring across the organisation’s entire IT environment, providing an ideal security overlay to SEACOM’s existing ICT solutions.

BT protects some of the world’s largest organisations from a myriad of fast-evolving cyber threats with a global network of dedicated 24/7 Security Operations Centres (SOCs). BT’s more than 3000 cyber security experts help customers detect, analyse and quickly respond to cybersecurity incidents as they happen.

“We’re excited to form this strategic alliance with BT and see the combined value of what we bring to our respective markets. With SEACOM’s global network and local presence, and BT’s global reach and expertise, we will be able to deliver a comprehensive portfolio of Cloud, security, and connectivity services that are reliable, scalable, and at the cutting-edge of industry,” says Oliver Fortuin, Group Chief Executive Officer of SEACOM.

Alessandro Adriani, director of system integrators and telecom service providers at BT’s Global unit, said: “We are thrilled to deliver BT’s world-class solutions to SEACOM and to their customers across the African continent. The areas of secure multi-cloud connectivity, next-generation networking solutions and collaboration services are the sweet spot where SEACOM and BT will combine their respective strengths.”

1...2,3102,3112,312...5,519Page 2,311 of 5,519